Australia, June 11 -- Denali Therapeutics Inc., owns the trademark (2611273) for 'AVLAYAH' till Nov. 3, 2035.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations for diagnosing and treating neurodegenerative diseases; pharmaceutical preparations for the treatment and prevention of lysosomal storage diseases.]
Type of Mark: Word
Date of Acceptance: Jan. 12
Registration Advertised: June 10
For further details contact Chelseaa Larsen Sheppard Mullin Richter & Hampton LLP .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2611273.
Disclaimer: Curated by HT Syndication.
